Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

by Children's Hospital BostonExtracellular vesicles, also known as exosomes, cross the blood-brain barrier via a transcytosis process. Credit: Kristin Johnson/Vascular Biology Program, Boston

Updated on: May 31,2024 4

Study details how exosomes, released by the breast tumor, tricks cells in the blood-brain barrier into taking them up

by Children's Hospital BostonExtracellular vesicles, also known as exosomes, cross the blood-brain barrier via a transcytosis process. Credit: Kristin Johnson/Vascular Biology Program, Boston

Updated on:May 31,2024 4

Biomarkers show promise for identifying early risk of pancreatic cancer

byDuke University Medical CenterCredit: Pixabay/CC0 Public DomainA research team at Duke Health has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are l

Updated on: January 04,2024 9

Biomarkers show promise for identifying early risk of pancreatic cancer

byDuke University Medical CenterCredit: Pixabay/CC0 Public DomainA research team at Duke Health has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are l

Updated on:January 04,2024 9

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024 0

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024 0

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines

Updated on: November 09,2024 0

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines

Updated on:November 09,2024 0

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-

Updated on: September 28,2024 0

Researchers customize top-of-the-line microscopy method with AI to better understand glioblastoma tumors

byEuropean Molecular Biology LaboratoryRationale and combined experimental/analysis pipeline for deep brain tumor imaging. Credit:Nature Communications(2024). DOI:10.1038/s41467-024-

Updated on:September 28,2024 0

Artificial intelligence-aided colonoscopy does not increase cancer detection

by Elana GotkineAdenoma and polyp detection rates (ADR/PDR) are lower with use of artificial intelligence-aided colonoscopy (AIAC), according to a study published in the November issue ofThe&nbs

Updated on: January 02,2024 9

Artificial intelligence-aided colonoscopy does not increase cancer detection

by Elana GotkineAdenoma and polyp detection rates (ADR/PDR) are lower with use of artificial intelligence-aided colonoscopy (AIAC), according to a study published in the November issue ofThe&nbs

Updated on:January 02,2024 9

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on: January 22,2024 18

Review covers progress in immunotherapy for esophageal cancer

by Cactus CommunicationsMultiple ongoing clinical trials are being conducted to test the potential of ICIs as an adjuvant therapy for resectable esophageal cancer. The results of these trials could ce

Updated on:January 22,2024 18

Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

byPerelman School of Medicine at the University of PennsylvaniaCD5 KO enhances CAR T cell cytotoxicity. Credit:Science Immunology(2024). DOI: 10.1126/sciimmunol.adn6509The effectiven

Updated on: August 03,2024 0

Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

byPerelman School of Medicine at the University of PennsylvaniaCD5 KO enhances CAR T cell cytotoxicity. Credit:Science Immunology(2024). DOI: 10.1126/sciimmunol.adn6509The effectiven

Updated on:August 03,2024 0

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou

Updated on: April 14,2024 10

Startup to commercialize blood test for most major cancers

by Paul Tumarkin,University of ArizonaCredit: University of ArizonaWhen testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, thou

Updated on:April 14,2024 10

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on: May 23,2024 3

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on:May 23,2024 3

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on: March 06,2024 17

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on:March 06,2024 17

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Updated on: February 18,2024 11

Study reveals persistent cancer disparities in Appalachian Kentucky

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA recent University of Kentucky Markey Cancer Center study published inThe Journal of Rural Healthsheds lig

Updated on:February 18,2024 11